▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2002 by analyst upside · 2026-08-13
MDGL
Madrigal Pharmaceuticals, Inc.
Healthcare · Market Cap $12B · P/E 0x
ANALYST PRICE TARGET
+26.5%
implied upside to consensus target
Current Price $536.2
Consensus Target $678.06
Bull Target $962.0
Bear Target $543.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
12
Hold
1
Sell
0
52-Week Low $351.32
52-Week High $615.0
YTD Return -9.7%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) N/A
Forward P/E 55.7x
EPS (TTM) $-14.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1.3B
Profit Margin -25.3%
52-WEEK RANGE
52-Week Low $351.32
52-Week High $615.0
Current Price $536.2
Bear Target $543.0
Bull Target $962.0
● Now $536.2 ● Target $678.06
TRADING DATA
Avg Volume 365K
YTD Return -9.7%
Analyst Count 16
Consensus Buy
Upside to Target +26.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Madrigal Pharmaceuticals, Inc. (MDGL) is currently trading at $536.2 with a Wall Street consensus price target of $678.06, implying potential upside of 26.5% over the next 12 months. 16 analysts currently cover MDGL, with a consensus rating of Buy - 94% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $962.0, while the most cautious has a target of $543.0.

MDGL operates in the Healthcare sector with a market capitalisation of $12B. The stock is down 9.7% year-to-date and is currently trading near the upper end of its 52-week range of $351.32 – $615.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DVA +20.3%
DaVita Inc.
$12B · P/E 15.4x · Hold
FMS +8.3%
Fresenius Medical Care AG
$13B · P/E 12.4x · Hold
UHS +12.5%
Universal Health Services, Inc.
$10B · P/E 7.0x · Hold
SOLV +10.1%
Solventum Corporation
$15B · P/E 10.4x · Hold
EXEL +5.1%
Exelixis, Inc.
$12B · P/E 15.8x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for MDGL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities - Reiterated
Neutral → Neutral 2026-06-11 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-05-13 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-05-07 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-05-07 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-05-06 31% win rate (48 calls)
B of A Securities - Reiterated
Neutral → Neutral 2026-02-20 Building track record
Barclays ● Initiated
Overweight 2026-01-28 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-01-20 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
58
out of 100
Coverage depth
22/30
Consensus clarity
14/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →